Skip to Main Content

212

Views

4

CrossRef citations to date

0

Altmetric

Letters to the Editor

Risk of hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients with myeloproliferative neoplasms treated with ruxolitinib

Alejandro Garcia-HortonMedical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada

https://orcid.org/0000-0003-0579-6709 View further author information

,

Elliot SmithMedical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, CanadaView further author information

,

Dawn MazeMedical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, CanadaView further author information

,

Caroline McNamaraMedical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, CanadaView further author information

,

Hassan SibaiMedical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, CanadaView further author information

&

Vikas GuptaMedical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, CanadaCorrespondence[email protected]
View further author information